相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human papillomavirus and cervical cancer
Kehinde Sharafadeen Okunade
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future
Yi Huang et al.
PURINERGIC SIGNALLING (2019)
HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1
Maria de Lourdes Mora-Garcia et al.
MEDIATORS OF INFLAMMATION (2019)
Cervical Cancer Cells Express Markers Associated with Immunosurveillance
Adriana Gutierrez-Hoya et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
The role of P2X7 receptor in prognosis and metastasis of colorectal cancer
Ying Zhang et al.
ADVANCES IN MEDICAL SCIENCES (2019)
Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives
Chee Kai Chan et al.
JOURNAL OF ONCOLOGY (2019)
Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1
Rosario Garcia-Rocha et al.
CYTOKINE (2019)
CD73 as a potential opportunity for cancer immunotherapy
Ghasem Ghalamfarsa et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Genomic characterization of cervical cancer based on human papillomavirus status
Liya Zhang et al.
GYNECOLOGIC ONCOLOGY (2019)
The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
Elena De Marchi et al.
ONCOGENE (2019)
Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer
Amirhossein Bahreyni et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2018)
Integrated analysis of HPV-mediated immune alterations in cervical cancer
Long Chen et al.
GYNECOLOGIC ONCOLOGY (2018)
Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review)
Daniel Boda et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
PHARMACOLOGY OF ADENOSINE RECEPTORS: THE STATE OF THE ART
Pier Andrea Borea et al.
PHYSIOLOGICAL REVIEWS (2018)
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Luiz E. B. Savio et al.
FRONTIERS IN PHARMACOLOGY (2018)
Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity
Milka Koupenova et al.
FRONTIERS IN PHARMACOLOGY (2018)
Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation
Francesco Di Virgilio et al.
FRONTIERS IN PHARMACOLOGY (2018)
Targeting adenosine for cancer immunotherapy
Robert D. Leone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Adenosinergic signaling as a target for natural killer cell immunotherapy
Jiao Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Molecular mechanisms of viral oncogenesis in humans
Nathan A. Krump et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Extracellular vesicles in cancer immune responses: roles of purinergic receptors
Michael W. Graner
SEMINARS IN IMMUNOPATHOLOGY (2018)
The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases
Margarete Dulce Bagatini et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress
Simona Roxana Georgescu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
Suellen Herbster et al.
CLINICS (2018)
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Francesco Di Virgilio et al.
NATURE REVIEWS CANCER (2018)
Extracellular purines, purinergic receptors and tumor growth
F. Di Virgilio et al.
ONCOGENE (2017)
The P2X7 Receptor in Infection and Inflammation
Francesco Di Virgilio et al.
IMMUNITY (2017)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
A Purinergic Trail for Metastases
Davide Ferrari et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Why Human Papillomavirus Acute Infections Matter
Samuel Alizon et al.
VIRUSES-BASEL (2017)
Purinergic Signalling: Therapeutic Developments
Geoffrey Burnstock
FRONTIERS IN PHARMACOLOGY (2017)
The P2X7 Receptor- Interleukin-1 Liaison
Anna Lisa Giuliani et al.
FRONTIERS IN PHARMACOLOGY (2017)
Multifaceted effects of extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host interaction and Therapeutic Perspectives
Paola de Andrade Mello et al.
FRONTIERS IN IMMUNOLOGY (2017)
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Ping Wee et al.
CANCERS (2017)
Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway
M. L. Mora-Garcia et al.
CELLULAR IMMUNOLOGY (2017)
Targeting immunosuppressive adenosine in cancer
D. Vijayan et al.
NATURE REVIEWS CANCER (2017)
P2X7 antagonists for CNS indications: recent patent disclosures
Paolo Pevarello et al.
PHARMACEUTICAL PATENT ANALYST (2017)
CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity
Zhao-wei Gao et al.
BMC CANCER (2017)
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair
Franco Pandolfi et al.
CLINICAL THERAPEUTICS (2016)
Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions
Maria de Lourdes Mora-Garcia et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Thymidine 5′-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor
Edyta Gendaszewska-Darmach et al.
PURINERGIC SIGNALLING (2016)
Functional variant of the P2X7 receptor gene is associated with human papillomavirus-16 positive cervical squamous cell carcinoma
Yuh-Cheng Yang et al.
ONCOTARGET (2016)
Carcinogenic human papillomavirus infection
Mark Schiffman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Adenosine inhibits migration, invasion and induces apoptosis of human cervical cancer cells
Z. W. Gao et al.
NEOPLASMA (2016)
Purinergic regulation of the immune system
Caglar Cekic et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives
Sebastien Roger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Targeting Na+/K+-translocating adenosine triphosphatase in cancer treatment
Cameron T. Durlacher et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
Selective permeabilization of cervical cancer cells to an ionic DNA-binding cytotoxin by activation of P2Y receptors
Maurish Bukhari et al.
FEBS LETTERS (2015)
Link between chronic inflammation and human papillomavirus-induced carcinogenesis
Jose Verissimo Fernandes et al.
ONCOLOGY LETTERS (2015)
DAMPs from cell death to new life
Emilie Venereau et al.
FRONTIERS IN IMMUNOLOGY (2015)
Nucleotides Acting at P2Y Receptors: Connecting Structure and Function
Kenneth A. Jacobson et al.
MOLECULAR PHARMACOLOGY (2015)
Anti-CD73 therapy impairs tumor angiogenesis
Bertrand Allard et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells
Paola de Andrade Mello et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
Purinergic signalling in the reproductive system in health and disease
Geoffrey Burnstock
PURINERGIC SIGNALLING (2014)
The Roles of CD73 in Cancer
Zhao-wei Gao et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia
Kirvis Torres-Poveda et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
CD73 and adenosine generation in the creation of regulatory microenvironments
F. S. Regateiro et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
ENTPD1/CD39 is a promising therapeutic target in oncology
J. Bastid et al.
ONCOGENE (2013)
Purinergic signalling and cancer
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2013)
CD39 and CD73 in immunity and inflammation
Luca Antonioli et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Role of the purinergic system in patients with cervical intraepithelial neoplasia and uterine cancer
Paula Acosta Maldonado et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Expression of P2X7 Receptor Increases In Vivo Tumor Growth
Elena Adinolfi et al.
CANCER RESEARCH (2012)
Purines, Purinergic Receptors, and Cancer
Francesco Di Virgilio
CANCER RESEARCH (2012)
Cellular function and molecular structure of ecto-nucleotidases
Herbert Zimmermann et al.
PURINERGIC SIGNALLING (2012)
Adenosine receptors and cancer
Stefania Gessi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress
Vonetta M. Williams et al.
FUTURE VIROLOGY (2011)
Human Papillomavirus (HPV) E7 Induces Prolonged G2 following S Phase Reentry in Differentiated Human Keratinocytes
N. Sanjib Banerjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Human Papillomavirus Testing in the Prevention of Cervical Cancer
Mark Schiffman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The human P2X7 receptor and its role in innate immunity
J. S. Wiley et al.
TISSUE ANTIGENS (2011)
Immune cell regulation by autocrine purinergic signalling
Wolfgang G. Junger
NATURE REVIEWS IMMUNOLOGY (2011)
Expression of purinergic receptors and modulation of P2X7 function by the inflammatory cytokine IFNγ in human epithelial cells
Lynn Welter-Stahl et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Activation of P2X7-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice
Wen Fu et al.
BMC CANCER (2009)
Host immune responses to cervical cancer
Swati Patel et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2009)
P2X7-mediated chemoprevention of epithelial cancers
George I. Gorodeski
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
Gennady G. Yegutkin
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma
Akash M. Mehta et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells
Sonja Buvinic et al.
JOURNAL OF CELL SCIENCE (2007)
Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice
Toni Darville et al.
JOURNAL OF IMMUNOLOGY (2007)
Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells
Xin Li et al.
GYNECOLOGIC ONCOLOGY (2007)
The P2X7 receptor:: A novel biomarker of uterine epithelial cancers
Xin Li et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
The effect of adenosine 5′-triphosphate on calcium mobilization and cell proliferation in cervical cancer cells
Seok Geun Lee et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2006)
A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization
Ying-Hong Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells
Juan Manuel Alcocer-Gonzalez et al.
VIRAL IMMUNOLOGY (2006)
P2 receptors and cancer
N White et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium
S Locovei et al.
FEBS LETTERS (2006)
Endogenously expressed truncated P2X7 receptor lacking the C-terminus is preferentially upregulated in epithelial cancer cells and fails to mediate ligand-induced pore formation and apoptosis
Y. H. Feng et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2006)
Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors
AB Mackenzie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth
E Adinolfi et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: A historical perspective
MA Packham et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
Estrogen attenuates P2X7 -: Mediated apoptosis of uterine cervical cells by blocking calcium influx
GI Gorodeski
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
Differential signalling of purinoceptors in HeLa cells through the extracellular signal-regulated kinase and protein kinase C pathways
A Muscella et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
P2X7 receptor-mediated apoptosis of human cervical epithelial cells
QF Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
A glance at adenosine receptors: novel target for antitumor therapy
S Merighi et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells
A Muscella et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
ATP-induced calcium oscillations and change of P2Y subtypes with culture conditions in HeLa cells
A Okuda et al.
CELL BIOCHEMISTRY AND FUNCTION (2003)
Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+-ATPase in HeLa cells
A Muscella et al.
CELLULAR SIGNALLING (2003)
Expression of glucose transporter-1 in cervical cancer and its precursors
LE Mendez et al.
GYNECOLOGIC ONCOLOGY (2002)
Expression, regulation, and function of P2X(4) purinergic receptor in human cervical epithelial cells
GI Gorodeski
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Molecular pharmacology of P2Y-receptors
I von Kügelgen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
分享论文
